| Authors: |
Vega Ocasio D; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Patel NN; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Leidman E; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Marcenac P; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Carreon JD; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Iwamoto C; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Soto GM; Clinical Trials Unit, U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), Lima, Peru., Westercamp M; Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bollinger S; Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Romero C; Vysnova Partners, Inc. (assigned to Clinical Trials Unit, NAMRU SOUTH), Alexandria, Virginia, USA., Silva M; Clinical Trials Unit, U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), Lima, Peru., Prouty M; Clinical Trials Unit, U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), Lima, Peru., Lessa FC; Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Neyra J; Clinical Trials Unit, U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), Lima, Peru., Ponce D; Vysnova Partners, Inc. (assigned to Clinical Trials Unit, NAMRU SOUTH), Alexandria, Virginia, USA., Castillo R; Clinical Trials Unit, U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), Lima, Peru., Llanos-Cuentas A; Infectious Diseases and Tropical Medicine Department, Cayetano Heredia Hospital, Lima, Peru., Matos E; Infectious Diseases Department, Arzobispo Loayza National Hospital, Lima, Peru., Smith RM; Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Fowlkes A; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. |
